Stent placement can achieve same prognosis as endoscopic nasobiliary drainage in treatment of bile leakage after liver transplantation

Table 1 Demographics and characteristics, n (%) or mean ± SD

	ENBD (n = 40)	Stent (n = 9)	P value
Age, years	49.83 ± 10.25	51.56 ± 7.30	0.000
Male	35 (87.5)	7 (77.8)	0.451
Cause for LT			0.946
Hepatocellular carcinoma	18 (45.0)	5 (55.6)
Decompensated cirrhosis	12 (30.0)	2 (22.2)
Acute-on-chronic liver failure	4 (10)	1 (11.1)
Acute liver failure	1 (2.5)	1 (11.1)
Others	5 (12.5)	0
TB	57.77 ± 49.96	102.22 ± 98.45	0.000
DB	44.51 ± 42.61	78.33 ± 81.31	0.001
WBC	7.58 ± 4.11	9.18 ± 7.23	0.030
CRP	37.33 ± 39.18	31.30 ± 34.82	0.931
PCT	2.38 ± 5.25	1.20 ± 1.51	0.263
Ab	36.85 ± 3.61	38.64 ± 4.52	0.357
AST	134.82 ± 346.01	54.22 ± 29.24	0.198
ALT	177.90 ± 236.18	130.78 ± 152.20	0.460
GGT	162.08 ± 145.97	119.22 ± 59.37	0.089
ALP	134.95 ± 86.02	136.11 ± 66.70	0.230
T-tube placement	4 (10)	2 (22.2)	0.312
Fever	14 (35)	3 (33.3)	0.885

ENBD: Endoscopic nasobiliary drainage; LT: Liver transplantation; TB: Total bilirubin; DB: Direct bilirubin; WBC: White blood cell; CRP: C-reactive protein; PCT: Procalcitonin; Ab: Albumin; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; GGT: Gamma-glutamyl transpeptidase; ALP: Alkaline phosphatase.

Table 2 Prognosis and stricture, n (%)

	ENBD (n = 40)	Stent (n = 9)	P value	Binary logistic regression
Recovery	28 (70)	8 (88.9)	0.412	0.292
Biliary stricture	9 (28)	2 (7)	1.0	0.890

ENBD: Endoscopic nasobiliary drainage.